ReeXploration Identifies Large-Scale Uranium Target at Eureka Project, Namibia
Discovery of uranium mineralization in ideal geological setting, supported by regional radiometric anomaly, confirms large Rossing-style target
ReeXploration Inc. (TSXV: REE) (FSE: K2I0) (‘ReeXploration’ or...
FORTUNE BAY ACCELERATES DEVELOPMENT AT GOLDFIELDS FOLLOWING STRONG PEA AND FINANCING
Development-ready gold asset in premier mining jurisdiction with funded advancement plan; preparing to initiate project-development and exploration drill program
Fortune Bay Corp. (TSXV: FOR,OTC:FTBYF) (FWB:...
1911 Gold Announces C$20 Million “Best Efforts” Life Offering and Private...
/ NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES /
1911 Gold Corporation (‘ 1911 Gold...
Osisko Intersects 330.6 Metres Averaging 0.46% Cu in Southern Extension at...
Osisko Metals Incorporated (the ‘ Company or ‘ Osisko Metals ‘) ( TSX: OM,OTC:OMZNF ; OTCQX: OMZNF ; FRANKFURT: 0B51 ) is pleased to...
CHARBONE confirme le respect de l’echeancier de construction a Sorel-Tracy et...
(TheNewswire)
Brossard, Quebec TheNewswire – le...
CHARBONE Confirms Construction Schedule on Track at Sorel-Tracy and Announces the...
(TheNewswire)
Brossard, Quebec TheNewswire – November...
Terra Clean Closes the Acquisition of the Past Producing Uranium Claims...
Terra Clean Energy CORP. (‘ Terra ‘ or the ‘ Company ‘) (CSE: TCEC,OTC:TCEFF, OTCQB: TCEFF FSE: C 9O0) is pleased to announce that,...
Mark Skousen: Gold, Silver in Major Bull Market, “Permanent Inflation” is...
Mark Skousen of Forecasts & Strategies shares his outlook for gold, silver and the US economy.
‘We’ve entered an era of what I call...
Questcorp Mining Receives Initial Investment from U.K. Based Institutional Investor Sorbie...
Questcorp Mining Inc. (CSE: QQQ,OTC:QQCMF) (OTCQB: QQCMF) (FSE: D910) (the ‘Company’ or ‘Questcorp’) is pleased to announce that Sorbie Bornholm LP (‘Sorbie’), a UK...
InMed Pharmaceuticals: Innovating Cannabinoid-inspired Medicines, Backed by Real Revenue and Clear Path...
InMed Pharmaceuticals (NASDAQ: INM) pairs innovative therapeutic development in Alzheimer’s, ophthalmology, and dermatology with recurring revenue from its BayMedica manufacturing division — giving investors...
















